Drugs / Superfact
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02251925 | Sep 2012 → Oct 2015 | infertility disorder | Royan Institute | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Superfact | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02251925 ↗ |
| Action | Activate | “GnRH agonist (Superfact)” NCT02251925 ↗ |
| Route | Subcutaneous | “at a subcutaneous daily dose of 0.5 mg” NCT02251925 ↗ |